NHI.no
Annonse
Informasjon

Hypofysesykdommer

Sykdommer i hypofysen er ofte svulstsykdommer. Mange av disse svulstene produserer økte mengder av ett hormon, mens de kan medføre nedsatt produksjon av andre hormoner.

Hypofysesykdommer er sjeldne.

Sist oppdatert:

19. jan. 2021

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Hypofysesykdommer . Referanselisten for dette dokumentet vises nedenfor

  1. Chehade JM, Sultan S. Assessment of pituitary mass. BestPractice, last updated July 29, 2013.
  2. Lake MG, Krook LS, Gruz SV. Pituitary adenomas: an overview. Am Fam Physician 2013; 88: 319-27. American Family Physician
  3. Melmed S. Pituitary-tumor endocrinopathies. N Engl J Med 2020; 382:937-950. doi:10.1056/NEJMra1810772 DOI
  4. Lund-Johansen M, Aanderud S, Schreiner T, et al. Ikke-hormonproduserende hypofyseadenomer. Tidsskr Nor Lægeforen 2003; 123: 2253-6. PubMed
  5. Gittleman H, Ostrom QT, Farah PD, et al. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009. J Neurosurg 2014;121:527-535. PubMed
  6. Iacovazzo D, De Marinis L. Treatment of hyperprolactinemia in post-menopausal women: pros. Endocrine. 2015 Feb;48(1):76-8. doi: 10.1007/s12020-014-0377-9 DOI
  7. Jørgensen AP, Bollerslev J. Hyperprolaktinemi. Nasjonal veileder i endokrinologi. Sist oppdatert 03.01.2020. www.endokrinologi.no
  8. Osa LE, Horjen J, Aanderud S, Lund-Johansen M. Operativ behandling av hormonproduserende hypofyseadenomer. Tidsskr Nor Lægeforen 2006; 126: 1330-2. PubMed
  9. Rogers A, Karavitaki N, Wass JA. Diagnosis and management of prolactinomas and non-functioning pituitary adenomas. BMJ. 2014;349:g5390. doi: 10.1136/bmj.g5390. DOI
  10. Svartberg J, Carlsen J, Cappelen J, Aanderud S, Lund-Johansen M, Schreiner T et al. Hyperprolaktinemi og prolaktinom - utredning og behandling Tidsskr Nor Lægeforen 2002; 122: 494 - 8.
  11. Higham CE, Johannsson G, Shalet SM. Hypopituitarism.Lancet. 2016 Nov 12;388(10058):2403-2415. doi: 10.1016/S0140-6736(16)30053-8. Epub 2016 Mar 31. PMID: 27041067. PubMed
  12. Eda M, Saeki N, Fujimoto N, Sunami K. Demonstration of optic pathway in large pituitary adenoma on heavily T2 weighted MR images. Br J Neurosurg 2002; 16: 21 - 9. PubMed
  13. Famini P, Maya MM, Melmed S. Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab 2011;96:1633-1641. PubMed
  14. Chin BM, Orlandi RR, Wiggins RH 3rd. Evaluation of the sellar and parasellar regions. Magn Reson Imaging Clin N Am 2012;20:515-543. PubMed
  15. Jørgensen AP, Bollerslev J, Øystese KA, et al. Hypofyseadenom. Nasjonal veileder i endokrinologi, 26.02.2020. www.helsebiblioteket.no
  16. Gittoes NJL, Bates AS, Tse W, Bullivan B, Shephard MC, Clayton RN et al. Radiotherapy for pituitary tumours. Clin Endocrinol (Oxford)1998; 48: 331 - 7. PubMed
  17. Turner HE, Stratton IM, Byrne JV, Adams CBT, Wass JAH. Audit of selected patients with non-functioning piuitary adenomas treated without irradiation - a follow-up study. Clin Endocrinol (Oxford) 1999; 51: 281 - 4. PubMed
  18. Thoren M, Høybye C, Grenback E, Degerblad M, Rahn T, Hulting AL. The role of gamma knife radiosurgery in the management of pituitary adenomas. J Neurooncol 2001; 54: 197 - 203. PubMed
  19. Lillehei KO, Kirschmann DL, Kleinschmidt-Demasters BK, Ridgway EC. Reassessment of the role of radiation therapy in the treatment of endocrine inactive pituitary macroadenomas. Neurosurgery 1998; 43: 432 - 9. PubMed
  20. Suhardja A, Kovacs K, Rutka J. Genetic basis of pituitary adenoma invasiveness: a review. J Neurooncol 2001; 52: 195 - 204. PubMed
  21. Jonsson B, Nilsson B. The impact of pituitary adenoma on morbidity. Increased sick leave and disability retirement in a cross-sectional analysis of Swedish national data. Pharmacoeconomics 2000; 18: 73 - 81. PubMed
  22. Bates AS, Bullivant B, Sheppard MC, Stewart PM. Life expectancy following surgery for pituitary tumors. Clin Endocrinol 1999; 50: 315 - 9. PubMed
  23. Rosén T, Bengtsson B-Å. Premature mortality due to cardiovascular diseases in hypopituitarism. Lancet 1990; 336: 285 - 8. PubMed
Annonse
Annonse